March 1, 2021
Business News

The Law Offices of Frank R. Cruz Announces Investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (IMVT) on Behalf of Investors


LOS ANGELES–()–The Law Offices of Frank R. Cruz announces an investigation of Immunovant, Inc. f/k/a Health Sciences Acquisitions Corporation (“HSAC”, “Immunovant”, or the “Company”) (NASDAQ: IMVT) on behalf of investors concerning the Company’s possible violations of federal securities laws.

If you are a shareholder who suffered a loss, click here to participate.

On February 2, 2021, the Company issued a press release “announc[ing] a voluntary pause of dosing in its ongoing clinical trials for IMVT-1401.” The Company also disclosed that it “has become aware of a physiological signal consisting of elevated total cholesterol and LDL [low-density lipoproteins] levels in IMVT-1401-treated patients”…



Click here to view the original article.

Related Posts

You might also like ...

AON Splash Image
Angel Oak Financial Strategies Income Term Trust Declares March 2021 Distribution
More Than $1.5 Million in Micro-Grants Aids Colorado Governments
IMVT Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Immunovant, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm